Clinical trials
Recruiting Phase 3 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asan Medical Center | 1 |
| CSL Behring | 1 |
| Children's Oncology Group | 1 |
| City of Hope Medical Center | 1 |
| Kura Oncology, Inc. | 1 |
| Lakefront Biotherapeutics NV | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Novartis Pharmaceuticals | 1 |
| Ottawa Hospital Research Institute | 1 |
| Quetzal Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 12 |
| Leukemia | 2 |
| Agammaglobulinemia | 1 |
| Burkitt Lymphoma | 1 |
| Graft vs Host Disease | 1 |
| Hematologic Diseases | 1 |
| Influenza, Human | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Leukemia, Promyelocytic, Acute | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.